1)Early Treatment for Retinopathy of Prematurity Cooperative Group:Revised Indications for the Treatment of Retinopathy of Prematurity. Arch Ophthalmol 121:1684-1694, 2003
2)Kusaka S, Shima C, Wada K et al:Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity:a pilot study. Br J Ophthalmol 92:1450-1455, 2008
3)日下俊次:重症未熟児網膜症に対する治療法の進歩.日本医師会雑誌 138:1588-1599,2009
4)Mintz-Hittner HA, Kennedy KA, Chuang AZ:BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3 + retinopathy of prematurity. N Engl J Med 364:603-615, 2011
5)平岡美依奈・渡辺とよ子・川上 義・他:超低出生体重児における未熟児網膜症:東京都多施設研究.日眼会誌 108:600-605,2004
6)Sato T, Kusaka S, Shimojo H et al:Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 116:1599-1603, 2009
7)Moshfeghi DM, Berrocal AM:Retinopathy of prematurity in the time of bevacizumab:incorporating the BEAT-ROP results into clinical practice. Ophthalmology 118:1227-1228, 2011
8)Sato T, Wada K, Arahori H et al:Serum concentrations of bevacizumab(Avastin)and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 153:327-333, 2012